“STUDY OF FIBROSIS PATHWAYS (TGF-Β AND WNT SIGNALING) AS THERAPEUTIC TARGETS IN CHRONIC KIDNEY DISEASE” (2026) MSW Management Journal, 36(1s), pp. 2466–2470. doi:10.7492/6nvwdg38.